Ketogenic Diet: Effective Prevention and Treatment for type II diabetes and Obesity

Authors

  • Yiyuan Zhang

DOI:

https://doi.org/10.54097/jerfdw10

Keywords:

Ketogenic diet, T2DM, obesity, metabolism, insulin sensitivity.

Abstract

Diabetes and obesity have evolved into substantial societal challenges, demanding urgently needed, widely promotable solutions. The ketogenic diet, originally developed for treating epilepsy, finally with metabolic adjustments as a bonus, has garnered attention in recent years as a dominant model for weight loss and health improvement. This article seeks to delve into the effectiveness of the ketogenic diet in preventing and managing type II diabetes and obesity. The ketogenic diet involves a low-carb and high-fat and moderating protein approach. These dietary adjustments can have a favorable impact on blood sugar levels and overall health. Furthermore, the ketogenic diet has shown promise in enhancing metabolism and insulin sensitivity, offering potential benefits for preventing the recurrence of type II diabetes and obesity. Understanding the potential advantages of the ketogenic diet under these conditions may provide novel insights and strategies for its application as a valuable tool in addressing these pressing health concerns.

Downloads

Download data is not yet available.

References

Zhu H, Bi D, Zhang Y, et al. Ketogenic diet for human diseases: the underlying mechanisms and potential for clinical implementations. Signal Transduct Tar, 2022, 7 (1): 11.

Zi Yang. Effects of low-carbohydrate diet and ketogenic diet on glucose and lipid metabolism. Jiangnan University, 2021.

Li F, Shen Y, Chen Q, et al. Therapeutic effect of ketogenic diet treatment on type 2 diabetes. J Future Foods, 2022, 2 (2): 177 - 183.

Eslami O, Shidfar F, Dehnad A. Inverse association of long-term nut consumption with weight gain and risk of overweight/obesity: A systematic review. Nutr Res, 2019, 68: 1 - 8.

Sumithran P, Proietto J. Ketogenic diets for weight loss: a review of their principles, safety and efficacy. Obes Res Clin Pract, 2008, 2 (1): 1 - 13.

Larsen T M, Dalskov S M, van Baak M, et al. Diets with high or low protein content and glycemic index for weight-loss maintenance. New Engl J Med, 2010, 363 (22): 2102 - 2113.

Bostock E, Kirkby K C, Taylor B V, et al. Consumer reports of “keto flu” associated with the ketogenic diet. Front Nutr, 2020, 7: 20.

Fabbrocini G, Napolitano A, Masarà A, et al. 15 keto fluprostenol isopropyl ester (80 µgr/mL) gel for cosmetic eyelash growth and enhancement. J Cosmet Dermatol-Us, 2019, 18 (2): 545 - 549.

D’Andrea Meira I, Romão T T, Pires do Prado H J, et al. Ketogenic diet and epilepsy: what we know so far. Front Neurosci-Switz, 2019, 13: 5.

Goldberg I J, Ibrahim N, Bredefeld C, et al. Ketogenic diets, not for everyone. J Clin Lipidol, 2021, 15 (1): 61 - 67.

Moriyama K, Watanabe M, Yamada Y, et al. Protein-Losing Enteropathy as a Rare Complication of the Ketogenic Diet. Pediatr Neurol, 2020, 52 (5): 526 - 528.

Jain S, Rai R, Singh D, et al. Octanoic acid a major component of widely consumed medium-chain triglyceride ketogenic diet is detrimental to bone. Sci Rep-Uk, 2021, 11 (1): 7003.

Downloads

Published

29-12-2023